A 50% PAT Raise, Mid-Year — Can H2 Deliver It?
Regency delivered Q2 revenue of ₹44.3 crore (+469% YoY) and PAT of ₹10 crore, but raised its full-year PAT target 50% (₹25–30 → ₹40–42 Cr) on the back of strong H1 execution. The tension: H2 must accelerate PAT 2.4× to meet the new target, dependent on M&A closes in a compressed 3–9 month window.
The headline meets the tension
₹44.3 Cr
+469% YoY
₹10.0 Cr
+201% YoY
₹49.5 Cr rev, ₹16.3 Cr PAT
39% of raised FY27 PAT target
₹40–42 Cr
+50% from prior ₹25–30 Cr
The quarter itself is clean: MSME secured lending hit ₹420 crore of AUM (up from ₹160 crore YoY), digital platforms scaled to ₹125 crore H1 AUM, and consolidated revenue jumped to ₹44.3 crore. That's genuine outsize growth. But the real event was not the Q2 print—it was management raising the full-year PAT target 50% mid-year, from ₹25–30 crore to ₹40–42 crore. That raise is not a lowered bar: H1 actually delivered ₹16.3 crore PAT, putting the company 39% of the way to the new target with six months to go. The tension is simple: H2 must accelerate PAT from a ₹10 crore Q2 run-rate to ₹24–26 crore in the next two quarters—a 2.4× step—and that acceleration depends on M&A closes (digital platform, gold loans) completing on the 3–9 month timeline the company guided.
What holds up in management's claims
H1 revenue ₹49.5 Cr and PAT ₹16.3 Cr tracking to FY27 target of ₹80+ Cr and ₹40–42 Cr
Q2 delivered ₹44.3 Cr revenue (consolidated); H1 total ₹49.5+ Cr confirmed. H1 PAT ₹16.3 Cr = 39% of new ₹40–42 Cr target with 6 months left. Revenue pace requires ₹30.5+ Cr in H2; organic alone may deliver ₹25–27 Cr.
Supported
AUM at ₹610 crore as of Sept 30, tracking to ₹900–950 crore by FY27-end
₹610 Cr confirmed mid-year = 68% of new ₹900–950 Cr target. Prior guidance was ₹500–550 Cr; this is a 50% mid-year raise. Feasible but dependent on M&A (digital platform, gold loan acquisitions).
Supported, M&A-dependent
NPA under control at 0.99% Gross, 0.75% Net, with asset-backed recovery mechanisms
Gross NPA ₹6.2 Cr absolute (0.99% ratio); asset-backed recovery ₹2.5–2.75 Cr underway. Ratio rose from prior (lower) levels, but management attributes to portfolio mix (rapid secured MSME expansion, lower accruals initially). No unforeseen stress identified in call.
Supported; watch for portfolio mix stability
Cost of funds declined 100 bps in H1 (13.5% → 12.35%); targeting 10.75–11.5% by FY27-end (another 100 bps)
H1 drop from 13.5% to 12.35% confirmed via NCDs + term loans. Need 100 bps more (12.35% → 10.75–11.5% range) in H2. Aggressive but on stated track. If RBI policy stays elevated or funding tightens, guidance at risk.
Partial; execution dependent
What changed on this call
PAT guidance: ₹25–30 Cr → ₹40–42 Cr (+50%)
Revenue guidance: ₹75+ Cr → >₹80 Cr (+7%)
AUM target: ₹600 Cr → ₹900–950 Cr (+50%)
Cost of funds target: 11.75–12.5% → 10.75–11.5% (more aggressive)
M&A acceleration: ₹312 Cr preferential raise + digital platform + gold loan acquisitions disclosed
The M&A disclosure is new. Management announced a ₹312–313 crore preferential equity raise (corporate + AIF + fund house subscriptions secured) with explicit deployment: ₹100–125 crore for digital lending platform acquisition (Q3-Q4 expected close), ₹75 crore for gold loan business majority stake (50% structure, 2 companies under evaluation). This is not theoretical growth—the deals are in audit, closure window stated as 3–9 months, and the capital is earmarked. JetFund (digital lending) is already live; RegPay (RBI-licensed lending) is awaiting final approval this quarter. The ₹3,000 crore AUM by FY30 target, once a long-term aspiration, is now quantified with intermediate steps: ₹900–950 Cr by FY27-end (acquired), ₹2,000 Cr by FY28 (post-integration).
The bull-bear ledger
H1 execution validates the raise: ₹49.5 Cr revenue (61% of new ₹80+ target), ₹16.3 Cr PAT (39% of ₹40–42 target)
MSME secured book (₹420 Cr, 69% of AUM) differentiated vs. unsecured peers: 0.99% NPA vs. NBFC avg 2–3%
Digital lending (₹125 Cr H1 AUM) riding secular adoption wave; in-house platforms reduce CAC vs. 3rd-party facilitators
NIM expanded 404 bps YoY to 7.54% via cost-of-funds reduction + margin management
Capital raise (₹312 Cr) boosts net worth from ₹190 Cr to ₹290 Cr (+53%); D/E 2.66x (post-raise) allows further growth
H2 needs ₹24–26 Cr PAT to hit target—a 2.4× acceleration from Q2 run-rate; dependent on M&A closes in 3–9 month window
Cost-of-funds target (10.75–11.5%) needs another 100 bps in H2; if rates stay elevated, NIM + PAT pressure
Digital lending retention at 70% vs. competitor 80–85%; CAC inflation in salaried space competitive
Regulatory risk: RegPay RBI license pending; if delayed to FY28, ₹50 Cr AUM target slips
Sequential PAT slowdown (Q2 ₹10 Cr vs. implied Q1 ₹6.3 Cr moderation) flags acquisition costs, platform investment
Risks, ranked by how much they should concern a holder
M&A execution bunching in Q4; digital platform + gold loan closes in 3–9 month window
High₹40–42 Cr FY27 PAT target assumes both acquisitions close by Q4 and accrete meaningfully. If either slips to FY28, H2 PAT falls short, full-year misses guidance, and credibility resets. Integration complexity (new lending books, different underwriting) not fully modeled in call.
Cost-of-funds trajectory: need 100 bps more reduction (12.35% → 10.75–11.5%) by March 2027
HighManagement achieved 100 bps H1 via NCDs + term loans. H2 target assumes fresh borrowing momentum at lower rates. If RBI policy stays elevated or funding tightens (liquidity squeeze, rate-cut delay), cost-of-funds stalls above 11.5%, compressing NIM + PAT by ₹2–3 Cr full-year.
Digital lending retention at 70% (vs. competitor 80–85%); CAC inflation in salaried space
Medium₹125 Cr H1 AUM scaling fast, but if retention erodes below 65% or CAC rises (competitive pressure from larger peers), unit economics dilute. Acquisition of external digital platform may address this; timing matters.
Regulatory approval delays: RegPay RBI license pending (expected this quarter)
MediumRegPay targeting ₹50 Cr AUM by FY27-end and ~₹2 Cr monthly profit contribution. License approval is binary. If delayed to FY28, that AUM + profit defer, and H2 momentum weakens (JetFund already live; RegPay is the next step).
NPA migration if portfolio growth outpaces underwriting discipline or macro slowdown hits borrowers
MediumNPA rose to 0.99% (from prior, lower levels). MSME book (₹420 Cr, 69% of AUM) is collateral-backed (LTV 60%), but rapid growth increases vulnerability. If macro pressure hits MSME borrowers or recovery processes stall, NPAs could exceed 1.5% comfort zone, eroding profitability.
The market's view and position
Stock price: ₹64.57 as of Oct 29. Trend is bullish on the macro chart—trading above SMA20 (₹59.17), SMA50 (₹51.57), and SMA200 (₹38.26)—but the recent action tells a different story. The all-time high is ₹71.8; the stock is now 10% below that level. From the 52-week low of ₹22.71, it has rallied 184%, suggesting the market has already priced significant upside. RSI at 67 (neutral zone, not overbought) and normal volume suggest the post-result pop has faded or is in a consolidation phase. Ownership structure shows no FII, DII at 1.07%, promoter at 21.43%—with QoQ promoter selling of 231 bps (from 23.74% to 21.43% YoY). The -10% drawdown from ATH, paired with promoter trimming, hints the market is reassessing H2 execution risk after the PAT guidance raise.
The price action reconciles with the fundamental tension. H1 delivery (+469% revenue, +201% PAT) is real, and management's 50% guidance raise is grounded in that execution. But the subsequent consolidation reflects skepticism on whether H2 can sustain that momentum—a 2.4× PAT acceleration is not trivial, and it hinges on M&A closes + cost-of-funds staying on track. The stock's position 10% below ATH is not a capitulation; it's a pause for clarity. Holders should watch for: (1) Q3 M&A announcement or closure (digital platform acquisition timing), (2) cost-of-funds trends in quarterly data (Nov–Dec borrowing rate), and (3) RegPay RBI approval confirmation.
The debate
What to watch next
1 · Q3 M&A announcement or closure (digital platform acquisition)
Management guided 3–9 month closure window. First update comes in Q3 results or interim announcement. If the platform acquisition closes or near-closes in Q3, it validates the ₹40–42 Cr FY27 PAT target and lifts sentiment. Delay into Q4-only signals concentration risk.
2 · Cost-of-funds trend in Q3 results (Nov–Dec borrowing rate)
H1 achieved 100 bps drop (13.5% → 12.35%). H2 needs another 100 bps (to 10.75–11.5%). Q3 results will show if fresh NCDs + term loans are being raised at lower rates or if borrowing momentum has stalled. If cost of funds stays above 12%, NIM pressure + PAT miss is the consequence.
3 · RegPay RBI license approval (expected this quarter)
Binary event. If approved by Dec 2026, ₹50 Cr AUM target by FY27-end becomes feasible, and profit contribution in Q4 is on track. If delayed, the entire RegPay ₹50 Cr + ₹2 Cr monthly profit plan shifts to FY28, weakening H2 momentum. Management has emphasized this; approval or delay will be disclosed.
The number to track from here
Consolidated PAT for H2 (Q3 + Q4 combined): ₹24–26 crore. That is the make-or-break metric for the ₹40–42 crore FY27 guidance. Q2 alone was ₹10 crore; H2 must double that with M&A integration costs still flowing. If H2 PAT lands above ₹24 crore, the guidance is credible, and the bull case holds for FY28 momentum. If it lands below ₹22 crore, the company has missed guidance, and the market will re-price. Watch this closely in Q3 results (Jan–Feb 2027) and Q4 update (March–April 2027).
Regency Fincorp is not a mid-cycle stumble story. H1 delivered outsized growth, and management raised full-year targets with numbers that reflect the company is 39% of the way to a new ₹40–42 crore PAT target mid-year. That is a material step-change in business quality. But the real earnings story—the one the stock's 10% pullback from ATH reflects—is H2 execution. M&A closes, cost-of-funds trajectory, digital lending retention, and NPA stability are not unknowns; they are the four pillars holding up the ₹40–42 crore guidance. If management delivers on 3 of 4, the stock reprices higher. If it stumbles on 2 or more, the updated guidance resets.
For now, treat the stock as a disciplined wait-and-see. H1 has given you real confidence in management's execution and numbers. Q3 results (M&A progress, cost of funds, AUM) will either confirm or refute whether the upgrade is durable. Until then, 10% below ATH is a pause, not a crash.
Informational and educational content only. Not investment advice.